Skip to main content
a b c d e f g h i j k l m n o p q r s t u v w x y z #

Referred Work

FK 506 (Tacrolimus or Prograf)

FK 506 (Tacrolimus or Prograf)

Immediately post transplant 10-15 ug/L.

After immediate post transplant period: 5-10 ug/L.

Ranges for guidance only.

 

Ganglioside Antibodies

Ganglioside Antibodies

Range provided by reference laboratory Normal range (IgG & IgM) <1/500

Infliximab drug monitoring

Infliximab drug monitoring

Please use drug levels as a guide. Infliximab Interpretation: Therapeutic drug levels: >2 µg/mL Intermediate drug levels: 1.0 – 2.0 µg/mL Subtherapeutic drug levels: < 1.0 µg/mL Test interpretation requires full clinical information: drug dosage/frequency, previous exposure to other biologics, time of sampling, duration of therapy and clinical assessment.

Infliximab drug monitoring

Infliximab drug monitoring

Please use drug levels as a guide. Infliximab Interpretation: Therapeutic drug levels: >2 µg/mL Intermediate drug levels: 1.0 – 2.0 µg/mL Subtherapeutic drug levels: < 1.0 µg/mL Test interpretation requires full clinical information: drug dosage/frequency, previous exposure to other biologics, time of sampling, duration of therapy and clinical assessment.

Neurone Specific Enolase (NSE)

Neurone Specific Enolase (NSE)

Provided by Reference Lab

NMDA receptor antibodies

NMDA receptor antibodies

Normal result is Negative

Pneumococcal serotype specific antibodies

Pneumococcal serotype specific antibodies

>0.35 ug/mL for each individual serotype
Pneumococcal serotype specific antibodies

Pneumococcal serotype specific antibodies

>0.35 ug/mL for each individual serotype
<<  1 [23  >>